Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Mission Therapeutics Raises $13.3M From Existing Strategic Investors
Growth StageVenture Capital

Mission Therapeutics Raises $13.3M From Existing Strategic Investors

•October 15, 2025
•Oct 15, 2025
0

Participants

Mission Therapeutics

Mission Therapeutics

company

Pfizer

Pfizer

investor

Sofinnova Partners

Sofinnova Partners

investor

Roche

Roche

investor

SR One

SR One

investor

IP Group

IP Group

investor

Rosetta Capital

Rosetta Capital

investor

Deal Summary

Mission Therapeutics, a Cambridge clinical-stage biotech focused on enhancing mitophagy, raised $13.3M in a financing led by its existing investors to advance its therapeutic programs. Lead investors include Pfizer Venture Investments, Sofinnova Partners, Roche Venture Fund, SR One, IP Group and Rosetta Capital.

0

Comments

Want to join the conversation?

Loading comments...